Ribonucleic Acid News and Research

RSS
Host and in vitro genomic variability of SARS-CoV-2 and its variants

Host and in vitro genomic variability of SARS-CoV-2 and its variants

Structure-guided virtual screening identifies novel SARS-CoV-2 Mpro inhibitors

Structure-guided virtual screening identifies novel SARS-CoV-2 Mpro inhibitors

Genetic variations affect and rewire phosphorylation signaling networks in SARS-CoV-2 infection

Genetic variations affect and rewire phosphorylation signaling networks in SARS-CoV-2 infection

Extended host range for SARS-CoV-2 variants of concern

Extended host range for SARS-CoV-2 variants of concern

Immunity found 6 months after SARS-CoV-2 infection in children

Immunity found 6 months after SARS-CoV-2 infection in children

Do we need COVID-19 vaccine boosters?

Do we need COVID-19 vaccine boosters?

An analysis of SARS-CoV-2 breakthrough infections by variant and vaccine

An analysis of SARS-CoV-2 breakthrough infections by variant and vaccine

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

Vaccination provides full protection against severe outcomes of COVID-19 among U.S. Coast Guard

Vaccination provides full protection against severe outcomes of COVID-19 among U.S. Coast Guard

COVID-19 vaccine boosters to prevent breakthrough SARS-CoV-2 infections in healthy adults

COVID-19 vaccine boosters to prevent breakthrough SARS-CoV-2 infections in healthy adults

The antimicrobial properties of the lungfish cocoon

The antimicrobial properties of the lungfish cocoon

Vaccine-induced immune responses for SARS-CoV-2 in patients receiving anti-CD20 B-cell depleting therapies

Vaccine-induced immune responses for SARS-CoV-2 in patients receiving anti-CD20 B-cell depleting therapies

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

Antigenic cocktail produced in Nicotiana benthamian plant as a potential COVID-19 vaccine candidate

Antigenic cocktail produced in Nicotiana benthamian plant as a potential COVID-19 vaccine candidate

Inactivated virion-based vaccine confers robust cell-mediated immunity against major SARS-CoV-2 variants

Inactivated virion-based vaccine confers robust cell-mediated immunity against major SARS-CoV-2 variants

Preexisting rhinovirus infection and IFN induction in epithelium of asthma patients decreases SARS-CoV-2 infection

Preexisting rhinovirus infection and IFN induction in epithelium of asthma patients decreases SARS-CoV-2 infection

Paper-based innovations for COVID-19 diagnosis

Paper-based innovations for COVID-19 diagnosis

Detection of SARS-CoV-2 spike antibody using electrochemical biosensing based on hydrogen bonding

Detection of SARS-CoV-2 spike antibody using electrochemical biosensing based on hydrogen bonding

SARS-CoV-2 infection and reinfection in farmed mink

SARS-CoV-2 infection and reinfection in farmed mink

Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.